Capture Body Composition Imaging Biomarkers with Confidence
The development of GLP-1 agonists and other therapies for weight loss and obesity is evolving and so is the advancement of imaging biomarkers for body composition profiling. The options to delineate and quantify muscle and lean mass are getting more sophisticated, so determining which imaging modality, anatomical coverage, and analysis methods to use can be critical to your obesity clinical trial outcomes.
Perceptive Imaging combines the right experience and the right people to help you navigate the nuances of imaging in weight loss clinical trials and to drive the success of your development program.
Image credit: AMRA Medical
Perceptive has provided imaging services to quantify lean and/or adipose tissue in nearly 80 clinical trials to date, contributing to 8 regulatory approvals.
You can rely on the scientific experts at Perceptive Imaging to identify the appropriate techniques to meet your weight loss clinical trial objectives. Their in-depth understanding of the different modalities involved in body composition imaging, including DXA, CT, and MRI and can help you reliably measure muscle and fat changes in the whole body or at specific anatomic locations.
Learn why you can rely on Perceptive Imaging for your obesity clinical trials.
Perceptive’s expertise spans the gamut of imaging that’s required to demonstrate safety and efficacy during obesity clinical trials, including:
Learn more about Perceptive’s expertise in weight loss clinical trial imaging
